Fenfluramine hydrochloride is an indirect 5-HT receptor agonist that was used as an anoretic i.e. an appetite reduction drug, sold under the brand name Pondimin.
It was removed from sale in 1997 because of significant safety fears that it contributed to the development of cardiac valvular disease.
Some people believe that it was a beneficial intervention for some of the problems faced by people with autism, although this was disputed by others.
This glossary is designed to explain some of the jargon and gobbledygook used by some people when they talk about autism or research..
You may be able to find more information, including links to other parts of this website, by clicking on the title of an item.
If you can't find the word you are looking for, or you know of a word we should include, please email firstname.lastname@example.org
The fact that an intervention is listed in this glossary does not necessarily mean that we agree with its use. Nor does it necessarily mean that there is any scientifically valid or reliable evidence behind it.